The development of tendon tissue engineering and regenerative medicine depends heavily on whether in vitro mechanical stimulation can faithfully ...

Kazia Therapeutics is paying $1.4 million upfront to secure a platform for generating epigenetic drugs from an Australian research institute. Brisbane-based QIMR Berghofer develop ...

Kazia Therapeutics Limited , a clinical-stage oncology company advancing therapies to reprogram cancer biology and overcome treatment resistance, announces the in-licensing of a first-in-class ...

Though many studies approach the developmental disorder Rett syndrome as a single condition arising from general loss of ...